Risk of diabetes up in hodgkin's lymphoma survivors

August 27, 2014
Risk of diabetes up in hodgkin's lymphoma survivors

(HealthDay)—Para-aortic radiation correlates with increased diabetes mellitus (DM) risk for Hodgkin's lymphoma (HL) survivors, according to a study published online Aug. 25 in the Journal of Clinical Oncology.

Frederika A. van Nimwegen, from the Netherlands Cancer Institute in Amsterdam, and colleagues examined the correlation between treatment for HL and DM risk in a cohort of 2,264 five-year HL survivors. Participants were diagnosed before age 51 years and received treatment between 1965 and 1995. Medical records and general practitioners provided treatment and follow-up information.

The researchers found that 157 patients developed DM after a median follow-up of 21.5 years. After 30 years, the overall cumulative incidence of DM was 8.3 percent. The cumulative incidence of DM was 14.2 percent after para-aortic radiation with ≥36 Gy. The risk of DM was increased 2.30-fold with irradiation with ≥36 Gy to the para-aortic lymph nodes and spleen, while the risk was increased 1.82-fold with para-aortic radiation alone with ≥36 Gy. The risk of DM was not significantly increased with lower doses (10 to 35 Gy). Higher mean to the pancreatic tail correlated with significantly increased risk of DM (P < 0.001).

"Screening for DM should be considered in follow-up guidelines for HL , and treating physicians should be alert to this increased risk," the authors write.

Explore further: Increased risk for head, neck cancers in patients with diabetes

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Increased risk for head, neck cancers in patients with diabetes

July 24, 2014
Diabetes mellitus (DM) appears to increase the risk for head and neck cancer (HNC). Evidence suggests certain cancers are more common in people with DM, but the risk of HNC in patients with DM has not been well explored. ...

Review: Recently diagnosed diabetes linked to pancreatic CA

March 24, 2014
(HealthDay)—There is a strong association between pancreatic ductal adenocarcinoma (PDAC) and recently diagnosed diabetes mellitus (DM), according to a systematic review and meta-analysis published in the March issue of ...

Specificity up with stereoscopic mammography for CA detection

January 18, 2013
(HealthDay)—Three-dimensional stereoscopic digital mammography (DM) significantly improves the specificity and accuracy of breast cancer detection, with a lower patient recall rate and a sensitivity comparable to that of ...

Psoriasis tied to increased risk of new-onset diabetes

March 27, 2013
(HealthDay)—Psoriasis is significantly tied to an increased risk of new-onset diabetes mellitus (DM), according to a study published online March 14 in Diabetes Care.

Fracture prediction methods may be useful for patients with diabetes

May 31, 2011
Use of established fracture prediction methods in older patients with type 2 diabetes mellitus (DM) found that scores from these methods were associated with hip and nonspine fracture risk, and a certain score associated ...

Diabetes, poor glucose control associated with greater cognitive decline in older adults

June 18, 2012
Among well-functioning older adults without dementia, diabetes mellitus (DM) and poor glucose control among those with DM are associated with worse cognitive function and greater cognitive decline, according to a report published ...

Recommended for you

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

FDA approves first drug for tumors tied to breast cancer genes

January 12, 2018
(HealthDay)—The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.